Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/05/2010WO2010087594A2 Cd93 or use of soluble fragment thereof
08/05/2010WO2010087577A2 Use of thymus capitatus extract, satureja hortensis extract, or carvacrol for treating metabolic diseases
08/05/2010WO2010087565A2 Novel use of piperine
08/05/2010WO2010087527A1 Ultraviolet absorbers, and pharmaceutical compositions and cosmetics containing pyrimidine compounds for uv protection
08/05/2010WO2010087521A1 Combined preparation for treating joint diseases
08/05/2010WO2010087517A1 Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism
08/05/2010WO2010087515A1 Fused ring compound and use thereof
08/05/2010WO2010087471A1 Hydroxypyrazinecarboxamide derivatives
08/05/2010WO2010087467A1 Delta-5-desaturase inhibitors
08/05/2010WO2010087454A1 Quinoline derivative
08/05/2010WO2010087447A1 Finely pulverized pharmaceutical composition
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087425A1 Prostate cancer progression inhibitor and progression inhibition method
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010087373A1 Method for producing extract of astaxanthin-containing yeast belonging to genus phaffia
08/05/2010WO2010087358A1 Novel composition
08/05/2010WO2010087315A1 Anti-alzheimer’s disease agent
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087306A1 Anti-neurodegenerative disease agent
08/05/2010WO2010087294A1 Triazolopyrimidine derivative or its salt, process for producing the same and pesticide containing the same
08/05/2010WO2010087260A1 Anti-tuberculosis agent and use thereof
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010087207A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
08/05/2010WO2010087150A1 Gastric acid secretion inhibitor, and potassium channel inhibitor
08/05/2010WO2010087107A1 Melanoma metastasis inhibitor
08/05/2010WO2010086972A1 Antistress agent
08/05/2010WO2010086964A1 Combination therapy for treating cancer
08/05/2010WO2010086868A1 Pharmaceutical compositions of trimetazidine
08/05/2010WO2010086864A1 Methods and compositions for treating alzheimer's disease
08/05/2010WO2010086820A1 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
08/05/2010WO2010086746A2 Compositions and methods of treating viral infections
08/05/2010WO2010086736A2 Novel use of the combination of resveratrol with cysteine and derivatives thereof
08/05/2010WO2010086732A1 Stable compositions for nail and skin treatment
08/05/2010WO2010086727A1 Stable compositions for nail onychomycosis treatment
08/05/2010WO2010086725A1 Compositions for nail and skin treatment
08/05/2010WO2010086723A1 Terbinafine compositions for onychomycosis treatment
08/05/2010WO2010086709A1 Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
08/05/2010WO2010086696A1 Low-molecular-weight sulphated polysaccharides as candidates for anti-angiogenic therapy
08/05/2010WO2010086646A1 Scriptaid isosteres and their use in therapy
08/05/2010WO2010086638A1 Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases
08/05/2010WO2010086637A1 Treatment of psoriasis
08/05/2010WO2010086617A2 Treatment
08/05/2010WO2010086614A1 Treatment
08/05/2010WO2010086613A1 Compounds useful as inhibitors as ampk
08/05/2010WO2010086551A1 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
08/05/2010WO2010086534A1 Cosmetic composition containing ketogluconic acid derivatives
08/05/2010WO2010086484A1 Use of derivates of 6-substituted 3-phenylcoumarins and preparation of new derivates
08/05/2010WO2010086481A1 New family of antichagasics derived from imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxide
08/05/2010WO2010086454A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases
08/05/2010WO2010086441A1 Pharmaceutical composition comprising n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
08/05/2010WO2010086438A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
08/05/2010WO2010086427A1 Pharmaceutical forms for the release of active compounds
08/05/2010WO2010086425A1 Pharmaceutical forms for the release of active compounds
08/05/2010WO2010086411A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients
08/05/2010WO2010086403A1 Azetidines as histamine h3 receptor antagonists
08/05/2010WO2010086400A1 Combination treatment of breast cancer
08/05/2010WO2010086387A1 5-ht4 inhibitors for treating airway diseases, in particular asthma
08/05/2010WO2010086351A1 3'-n-substituted 9-deoxo-9a-methyl-9a-aza-homoerythromycin having antimalarial activity
08/05/2010WO2010086350A1 9-deoxo- 9a-methyl- 9a- aza- 9a-h0m0erythr0mycin a derivatives for the treatment of neutrophil dominated inflammatory diseases
08/05/2010WO2010086349A1 Anti-inflammatory macrolide
08/05/2010WO2010086331A2 Composition comprising caftaric acid and/or derivatives thereof
08/05/2010WO2010086322A1 Composition comprising chicoric acid and/or derivatives thereof
08/05/2010WO2010086315A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
08/05/2010WO2010086312A1 Galenic formulations of organic compounds
08/05/2010WO2010086280A1 Novel n-oxides of furanyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086279A1 Novel dibenzofuranyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086278A1 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086259A1 Piperidine derivatives as nk3 receptor antagonists
08/05/2010WO2010086251A1 Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
08/05/2010WO2010086197A1 Low molecular weight sulphated polysaccharides as candidates for anti-angiogenic therapy
08/05/2010WO2010086190A1 Method and device for detecting a substance applied onto a body part
08/05/2010WO2010086185A1 Nampt and vitamin b3 for treating or preventing diseases
08/05/2010WO2010086129A1 Inclusion complex comprising cinacalcet and cyclodextrin
08/05/2010WO2010086101A1 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
08/05/2010WO2010086040A1 Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
08/05/2010WO2010085968A1 Toluidine sulfonamides and their use as hif-inhibitors
08/05/2010WO2010085959A1 Treatment of radiation-induced fibrosis
08/05/2010WO2010085848A1 Drug abuse deterrent, methods and compositions
08/05/2010WO2010068935A3 Small molecule immunomodulators for alzheimer's disease
08/05/2010WO2010068913A3 Compositions of proton pump inhibitors, kits and methods of their use to treat diabetes
08/05/2010WO2010068500A3 PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
08/05/2010WO2010066931A4 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
08/05/2010WO2010066909A3 New inhibitors for treating diseases associated with an excess transport of hyaluronan
08/05/2010WO2010066901A3 Tetrahydrotriazine compounds for treating diseases associated with ampk activity
08/05/2010WO2010066749A3 Ulipristal acetate tablets
08/05/2010WO2010066689A3 Modulators of the interaction between cholesterol molecules and the epstein-barr virus induced receptor 2
08/05/2010WO2010066046A8 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
08/05/2010WO2010063476A3 Solid dosage forms of bendamustine
08/05/2010WO2010063470A3 Methods for preventing or reducing colon carcinogenesis
08/05/2010WO2010062322A3 Modulation of the immune response
08/05/2010WO2010062205A3 Indication of use of erdosteine as antidote in a large number of intoxications, especially in heavy metals like lead or mercury, and paracetamol
08/05/2010WO2010060522A3 Difluorphenyl diacylhydrazide derivates
08/05/2010WO2010059969A3 Use of anti-vegf antibody in combination with chemtherapy for treating breast cancer
08/05/2010WO2010059239A3 Lactate salt of 4-(6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
08/05/2010WO2010055119A3 Pharmaceutical composition comprising pimobendan
08/05/2010WO2010053580A3 Reducing the risk of smoke-related disease
08/05/2010WO2010051544A3 Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
08/05/2010WO2010045303A3 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
08/05/2010WO2010042867A3 Activators of human pyruvate kinase
08/05/2010WO2010040862A3 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer
1 ... 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 ... 7860